How ‘race-norming’ was built into the NFL concussion settlement
By Will Hobson,
The Washington Post
| 08. 02. 2021
The NFL and lawyers for former players blame the controversial practice on doctors. But both sides negotiated a settlement that guaranteed race would affect payouts — and defended the practice long after concerns were raised.
Licensed for use by CC BY-SA 2.0 on Wikimedia Commons
CHANDLER, Ariz. — At first glance, Rick Cunningham looks almost as formidable at 54 as he did during his playing days.
As the 6-foot-7, 270-pound former offensive tackle led a visitor into his home recently, the only visible sign that eight seasons in the National Football League inflicted any lasting damage was Cunningham’s deliberate gait, caused by chronic pain in knees surgically repaired nine times and hips that need replacing.
Then Cunningham tried to speak. Thoughts form in his head, he explained, but he has trouble finding the words. He stammered often, sometimes relying on his wife, Debbie, to translate. At one point, he gestured toward a pool table and explained — in a belabored, meandering way — that he couldn’t remember what to call the wooden pole resting across it.
“It’s a pool cue, hon,” Debbie said as she gently held his arm.
When the settlement in the landmark NFL class-action concussion litigation was finalized in 2017, and the league agreed to pay sums as high as $5...
Related Articles
By Liyan Qi and Jonathan Cheng, The Wall Street Journal | 03.26.2025
photo via Wikimedia Commons licensed under CC by 3.0
Chinese scientist He Jiankui set off global outrage and landed in prison after he skirted ethical guidelines and claimed he had produced genetically modified babies designed to resist HIV infection.
Now, the self-styled ...
By Carsten T. Charlesworth, Henry T. Greely, and Hiromitsu Nakauchi, MIT Technology Review | 03.25.2025
Why do we hear about medical breakthroughs in mice, but rarely see them translate into cures for human disease? Why do so few drugs that enter clinical trials receive regulatory approval? And why is the waiting list for organ transplantation...
By Anna Louie Sussman, The New York Times | 03.25.2025
On June 24, 2022, the same day the Supreme Court issued its decision in Dobbs v. Jackson Women’s Health Organization, I received a call from the fertility clinic where I’d been undergoing in vitro fertilization, informing me that seven of...
By Michael Gibney, PharmaVoice | 03.20.2025
The death this week of a teenager receiving Sarepta Therapeutics’ gene therapy Elevidys for Duchenne muscular dystrophy is a tragic reminder of the stakes involved in cutting-edge biotech innovation.
While gene therapies like Sarepta’s offer an opportunity to treat and...